Company Snapshot

Investment Thesis

Aflac sells supplemental insurance products in Japan and the U.S., generating stable float and investment income. Agents, bancassurance partnerships, and cancer insurance leadership sustain cash generation.

  • Japan Franchise: Deep relationships with Japan Post and banks drive policy sales.
  • Product Diversification: U.S. combines worksite benefits, dental/vision, and group offerings.
  • Capital Returns: Robust free cash flow funds dividends and buybacks.

Strategic Mix

Aflac Japan Cancer, medical, and savings products sold through banks and agencies
Aflac U.S. Accident, critical illness, hospital indemnity, and worksite benefits
Investments High-quality bond portfolio generating spread income
Strategic Ventures Digital health partnerships and asset management stakes

Mix mirrors Aflac’s Japan vs. U.S. reporting segments.

Recent Performance

MTD TBD
QTD TBD
YTD TBD
5Y TBD

Maxim is cueing up returns data for this security. Once the nightly supported.csv job runs, these metrics will auto-populate.

Strategic Insights

Product Innovation

New medical riders and savings products address aging populations in Japan.

Worksite Digitization

Enrollment tech and direct-to-consumer experiments broaden reach.

Currency & Hedging

USD/JPY hedges stabilize capital returns for U.S. investors.

Latest Coverage

Curated headlines sourced from Maxim’s AI newsroom.

Loading latest coverage...